CClinicalTrials.gg
CompletedNCT05822973Updated Apr 21, 2023

Sutures for Treatment of Knee Arthroscopy

An interventional study of 3.0 monocryl suture and 3.0 nylon suture in Knee Arthroscopy and Suture, sponsored by Rothman Institute Orthopaedics. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-21.

Sponsored by Rothman Institute Orthopaedics · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Apr 2023, 3 years 5 months ago, and no results have been posted to the registry.
  • Registered 4 years 4 months after the study started (first participant enrolled Nov 2018, registered Apr 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
274
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

For a knee arthroscopy, two small incisions are made at the level of the joint line on each side of the patellar tendon. Closure of surgical incisions consists of using either nonabsorbable or absorbable sutures. Some surgeons prefer using nonabsorbable sutures due to it being easier to tie, these sutures are less likely to break prematurely, and that they elicit a minimal inflammatory response. On the other hand, some surgeons prefer using absorbable sutures due to the time savings of not having to remove the sutures at a later date and that these sutures decrease patient anxiety and discomfort. The purpose of this study is to prospectively investigate and compare patient's pain, swelling and cosmesis following knee arthroscopy surgery between patients who had their arthroscopy portals closed using resorbable sutures vs. patients who had their portals closed using nonabsorbable sutures.

02

Conditions studied

  • Knee Arthroscopy
  • Suture
03

In context

Lead sponsor

Rothman Institute Orthopaedics is the lead sponsor of 118 studies on the registry; 17 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients ages 18 and older undergoing primary knee arthroscopy for diagnostic arthroscopy, removal of a loose body, chondroplasty, or a partial meniscectomy will be included in this analysis

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing revision knee arthroscopy as well as patients undergoing ACL reconstruction or meniscal repair surgery will be excluded from this analysis.
  • Patients under the age of 18 will be excluded as well.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
274 participants (actual)

Study arms

  • Active comparator
    would closure using absorbable sutures

    patients randomized into the absorbable suture group will have their incisions closed with 3.0 monocryl sutures

    Device: 3.0 monocryl suture

  • Active comparator
    would closure using non-absorbable sutures

    Patients randomized into the nonabsorbable suture group will have their incisions closed with either a 3.0 nylon suture

    Device: 3.0 nylon suture

Interventions

  • Device3.0 monocryl suture

    incision will be closed with absorbable suture

  • Device3.0 nylon suture

    incision will be closed with non-absorbable suture

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Leveles

    Pain levels will be recorded through the Visual Analogue Scale (VAS)

    Time frame: 3 months

  2. Patient Satisfaction

    Satisfaction will be measures with customized questions regarding the overall satisfaction of their incision (on a scale of 0 to 10), satisfaction of the suture removal process, complications and swelling

    Time frame: 3 months

07

Study locations

1 site
  • Rothman Orthopaedic Institute
    Philadelphia, Pennsylvania 19107, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05822973
Lead sponsor
Rothman Institute Orthopaedics
Responsible party
Sponsor
First posted
Apr 21, 2023
Start date
Nov 18, 2018
Primary completion
Apr 9, 2023
Completion
Apr 9, 2023
Last update
Apr 21, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion